Roche at ESMO 2022

Unlocking new possibilities for better cancer care.


To see where oncology care is headed, visit us at the ESMO Congress 2022 (Booth 306). We’ll share how our navify® Oncology portfolio supports comprehensive, personalised cancer care, providing holistic data-driven insights for improved clinical decision-making and operational efficiency.

Shaping the future of oncology care. It’s personal.

At Roche, we aim to create a more connected, secure and efficient healthcare system, where digital solutions clarify navigation throughout the oncology care continuum, unlocking new possibilities for better cancer care.

Our navify Oncology portfolio is designed to re-define patient management in oncology. With its intuitive and intelligent software, navify Oncology portfolio streamlines clinical workflows and improves collaboration across care teams, providing quick access to relevant, actionable data and up-to-date clinical insights for more effective care decisions and timely access to care—all in a secure, compliant environment. We are transforming the way cancer care is delivered.

Visit us at ESMO Congress 2022 (9-13 September, Paris) to discover how we are empowering care that is efficient, timely, and personalised.

End-to-end solutions across the cancer care continuum.

Visit our Booth 306 and learn more about our digital portfolio.

navify® Oncology Hub* – Helping oncologists overcome information overload and administrative burden, providing quick access to actionable, longitudinal patient data to enable more efficient care coordination and effective, patient-centric cancer care. Learn more

navify® Tumor Board Improving multidisciplinary tumor board preparation and discussion, enabling providers to securely access, review and share relevant health and medical data, resulting in more timely and personalised cancer care. Learn more

navify® Mutation Profiler Providing oncologists currently available targeted therapy and clinical options–based on genomic profiling test interpretation and report by molecular pathologists–for personalised care decisions. Learn more

*Product is commercially available in the United States and Taiwan, and being piloted in other selected markets.

We hope to see you in Paris!

Register today to meet our team in person,

find us at booth number 306.